These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial. Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M; Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608 [TBL] [Abstract][Full Text] [Related]
44. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Gawel M; Aschoff J; May A; Charlesworth BR; Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607 [TBL] [Abstract][Full Text] [Related]
45. [Triptanes in the treatment of migraine. A review based on three Cochrane reviews]. Tfelt-Hansen P; Iversen HK Ugeskr Laeger; 2006 May; 168(19):1850-3. PubMed ID: 16756800 [No Abstract] [Full Text] [Related]
46. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III. MacGregor EA; Brandes J; Eikermann A; Giammarco R Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259 [TBL] [Abstract][Full Text] [Related]
47. Predictors of adherence to triptans: factors of sustained vs lapsed users. Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501 [TBL] [Abstract][Full Text] [Related]
48. [Acute migraine. Sumatriptan-naproxen combination tablets work better than a single substance]. Kreutzkamp B Med Monatsschr Pharm; 2007 Sep; 30(9):348-9. PubMed ID: 17912879 [No Abstract] [Full Text] [Related]
49. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine. Natarajan S; Jabbour JT; Webster CJ; Richardson MS Headache; 2004; 44(10):969-77. PubMed ID: 15546259 [TBL] [Abstract][Full Text] [Related]
50. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan. Gregor N; Schlesiger C; Akova-Oztürk E; Kraemer C; Husstedt IW; Evers S Headache; 2005 Sep; 45(8):1069-72. PubMed ID: 16109122 [TBL] [Abstract][Full Text] [Related]
51. TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. Goadsby PJ; Dodick DW; Ferrari MD; McCrory DC; Williams P Acta Neurol Scand; 2004 Sep; 110(3):137-43. PubMed ID: 15285768 [TBL] [Abstract][Full Text] [Related]
53. Frovatriptan and data publication. Tfelt-Hansen P Headache; 2008 Oct; 48(9):1382-3. PubMed ID: 19006553 [No Abstract] [Full Text] [Related]
54. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials. Dahlöf CG Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262 [TBL] [Abstract][Full Text] [Related]